ZEN Graphene Solutions Ltd.: ZEN Graphene Solutions Provides Update on Cytotoxicity Testing of Graphene-Based Compound and Effectiveness of Graphene-Based Coating
ZEN Graphene Solutions Ltd. ("
ZEN" or the "
Company") (TSXV: ZEN) (OTC: ZENYF) is pleased to announce the following:
Preliminary cytotoxicity results of its graphene-based antibiotic, antiviral and antifungal compound show no apparent negative impacts in animals dosed with a concentration many thousands of times higher than that found to be effective in testing recently completed at Mount Sinai hospital. Phase 2 testing results expected in late-January
At 108 days, testing results of polypropylene mask material treated with ZEN's coating demonstrated 98% effectivity against COVID-19